791 related articles for article (PubMed ID: 19598071)
21. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
22. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
[TBL] [Abstract][Full Text] [Related]
23. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency.
Ivaskevicius V; Biswas A; Loreth R; Schroeder V; Ohlenforst S; Rott H; Krause M; Kohler HP; Scharrer I; Oldenburg J
Haemophilia; 2010 Jul; 16(4):675-82. PubMed ID: 20331752
[TBL] [Abstract][Full Text] [Related]
24. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
25. Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A
Ivaškevičius V; Biswas A; Garly ML; Oldenburg J
Haemophilia; 2017 May; 23(3):e194-e203. PubMed ID: 28520207
[TBL] [Abstract][Full Text] [Related]
26. Factor XIII deficiency: an update.
Schroeder V; Kohler HP
Semin Thromb Hemost; 2013 Sep; 39(6):632-41. PubMed ID: 23929307
[TBL] [Abstract][Full Text] [Related]
27. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
[TBL] [Abstract][Full Text] [Related]
28. Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Nugent D
Thromb Res; 2012 Dec; 130 Suppl 2():S12-4. PubMed ID: 23439001
[TBL] [Abstract][Full Text] [Related]
29. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
[TBL] [Abstract][Full Text] [Related]
30. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.
Borhany M; Handrkova H; Cairo A; Schroeder V; Fatima N; Naz A; Amanat S; Shamsi T; Peyvandi F; Kohler HP
Haemophilia; 2014 Jul; 20(4):568-74. PubMed ID: 24329762
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Management of Congenital and Acquired FXIII Deficiencies.
Muszbek L; Katona É
Semin Thromb Hemost; 2016 Jun; 42(4):429-39. PubMed ID: 27071048
[TBL] [Abstract][Full Text] [Related]
32. [Factor XIII in man: a review].
Dufner GS; Marbet GA
Hamostaseologie; 2002 Feb; 22(1):11-9. PubMed ID: 12193980
[TBL] [Abstract][Full Text] [Related]
33. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
Jang MA; Park YS; Lee KO; Kim HJ
Blood Coagul Fibrinolysis; 2015 Jan; 26(1):46-9. PubMed ID: 25004025
[TBL] [Abstract][Full Text] [Related]
34. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII.
Souri M; Koseki-Kuno S; Takeda N; Yamakawa M; Takeishi Y; Degen JL; Ichinose A
Thromb Haemost; 2008 Feb; 99(2):401-8. PubMed ID: 18278192
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Factor XIII.
Muszbek L; Katona É; Kerényi A
Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
[TBL] [Abstract][Full Text] [Related]
36. Factor XIII and atherothrombotic diseases.
Muszbek L; Bereczky Z; Bagoly Z; Shemirani AH; Katona E
Semin Thromb Hemost; 2010 Feb; 36(1):18-33. PubMed ID: 20391293
[TBL] [Abstract][Full Text] [Related]
37. Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.
Ivaškevičius V; Goldmann G; Biswas A; Westhofen P; Thomas A; Marquardt N; Horneff S; Klein C; Rühl H; Pötzsch B; Oldenburg J
Hamostaseologie; 2015; 35 Suppl 1():S32-5. PubMed ID: 26540128
[TBL] [Abstract][Full Text] [Related]
38. Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement.
Ma S; Chen C; Liang Q; Wu X; Wang X; Wu W; Liu Y; Ding Q
Orphanet J Rare Dis; 2019 Jul; 14(1):182. PubMed ID: 31340840
[TBL] [Abstract][Full Text] [Related]
39. Acquired plasma factor XIII deficiencies.
Tosetto A; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
[TBL] [Abstract][Full Text] [Related]
40. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
